Magnetobiosensors based on viral protein p19 for microRNA determination in cancer cells and tissues.

MicroRNAs (miRs) have emerged as important clinical biomarkers with both diagnostic and prognostic value for relevant diseases, such as cancer. MiRs pose unique challenges for detection and are currently detected by northern blotting, real-time PCR, and microarray techniques. These expensive, complicated, and time-consuming techniques are not feasible for on-site miR determination. In this study, amperometric magnetobiosensors involving RNA-binding viral protein p19 as a selective biorecognition element were developed for miR quantification. The p19-based magnetosensors were able to detect 0.4 fmol of a synthetic target and endogenous miR-21 (selected as a model for its role in a wide variety of cancers) in only 2 h in total RNA extracted from cancer cells and human breast-tumor specimens without PCR amplification and sample preprocessing. These results open up formidable perspectives for the diagnosis and prognosis of human cancers and for drug-discovery programs.

[1]  S. Yao,et al.  Carbon nanotube-based label-free electrochemical biosensor for sensitive detection of miRNA-24. , 2014, Biosensors & bioelectronics.

[2]  Pengbo Zhang,et al.  Highly sensitive and specific multiplexed microRNA quantification using size-coded ligation chain reaction. , 2014, Analytical chemistry.

[3]  M. Ozsoz,et al.  A new insight into electrochemical microRNA detection: a molecular caliper, p19 protein. , 2013, Biosensors & bioelectronics.

[4]  D. Kolpashchikov,et al.  Four-way junction formation promoting ultrasensitive electrochemical detection of microRNA. , 2013, Analytical chemistry.

[5]  M. Berezovski,et al.  Three-mode electrochemical sensing of ultralow microRNA levels. , 2012, Journal of the American Chemical Society.

[6]  Tugba Kilic,et al.  Electrochemical based detection of microRNA, mir21 in breast cancer cells. , 2012, Biosensors & bioelectronics.

[7]  Joshua T. Mendell,et al.  A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts , 2012, Nucleic acids research.

[8]  N. Akbar,et al.  Outcomes following B3/B4 needle core biopsy in South East London Breast Screening Service 2000 to 2010 , 2011, Breast Cancer Research.

[9]  Li Guo,et al.  Next-Generation Sequencing of MicroRNAs for Breast Cancer Detection , 2011, Journal of biomedicine & biotechnology.

[10]  Peng Wu,et al.  An enzyme-linked assay for the rapid quantification of microRNAs based on the viral suppressor of RNA silencing protein p19. , 2011, Analytical biochemistry.

[11]  Yan Zhang,et al.  Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth , 2011, Breast Cancer Research.

[12]  Jingmin Jin,et al.  Protein mediated miRNA detection and siRNA enrichment using p19. , 2010, BioTechniques.

[13]  Liang-Hu Qu,et al.  MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. , 2009, Biochemical and biophysical research communications.

[14]  S. Sagan,et al.  Cysteine residues of Carnation Italian Ringspot virus p19 suppressor of RNA silencing maintain global structural integrity and stability for siRNA binding. , 2009, Biochimica et biophysica acta.

[15]  Michael T. McManus,et al.  Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion* , 2009, The Journal of Biological Chemistry.

[16]  Suresh Shrestha,et al.  Bioluminescence-based detection of microRNA, miR21 in breast cancer cells. , 2008, Analytical chemistry.

[17]  L. Malinina,et al.  Recognition of small interfering RNA by a viral suppressor of RNA silencing , 2003, Nature.